# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA851014 | A | Percent bioavailability at 1 mg/kg intravenous administration and 2 mg/kg peroral administration | monkey | 1 | organism-based format | Scientific Literature | ||
2. | ALA851015 | A | Percent bioavailability at 1 mg/kg intravenous administration and 5 mg/kg peroral administration | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
3. | ALA851020 | A | Percent bioavailability at 0.5 mg/kg intravenous administration and 2 mg/kg peroral administration | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
4. | ALA841036 | A | Maximum time taken by the compound at 1 mg/kg intravenous administration and 2 mg/kg peroral administration | Cercopithecidae | 1 | organism-based format | Scientific Literature | ||
5. | ALA841037 | A | Maximum time taken by the compound at 1 mg/kg intravenous administration and 5 mg/kg peroral administration | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
6. | ALA841039 | A | Maximum time taken by the compound at 0.5 mg/kg intravenous administration and 2 mg/kg peroral administration | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
7. | ALA840684 | A | Vdss at 1 mg/kg intravenous administration and 2 mg/kg peroral administration | Cercopithecidae | 1 | organism-based format | Scientific Literature | ||
8. | ALA840685 | A | Vdss at 1 mg/kg intravenous administration and 5 mg/kg peroral administration | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
9. | ALA840686 | A | Vdss at 0.5 mg/kg intravenous administration and 2 mg/kg peroral administration | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
10. | ALA839079 | A | Half life at 1 mg/kg intravenous administration and 2 mg/kg peroral administration | Cercopithecidae | 1 | organism-based format | Scientific Literature | ||
11. | ALA839080 | A | Half life at 1 mg/kg intravenous administration and 5 mg/kg peroral administration | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
12. | ALA840021 | A | Half life at 0.5 mg/kg intravenous administration and 2 mg/kg peroral administration | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
13. | ALA839371 | A | Clearance at 1 mg/kg intravenous administration and 2 mg/kg peroral administration | Cercopithecidae | 1 | organism-based format | Scientific Literature | ||
14. | ALA839372 | A | Clearance at 1 mg/kg intravenous administration and 5 mg/kg peroral administration | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
15. | ALA839373 | A | Clearance at 0.5 mg/kg intravenous administration and 2 mg/kg peroral administration | Canis lupus familiaris | 1 | organism-based format | Scientific Literature | ||
16. | ALA828108 | B | Concentration for 50% inhibition of human melanocortin-1 receptor expressed in CHO cells using [125I]-NDP-alpha-MSH as radioligand | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA828109 | B | Concentration for 50% inhibition of human melanocortin-3 receptor expressed in CHO cells using [125I]NDP-alpha-MSH as radioligand | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
18. | ALA828110 | B | Concentration for 50% inhibition of human melanocortin-4 receptor expressed in CHO cells using [125I]NDP-alpha-MSH as radioligand | Homo sapiens | 10 | cell-based format | Scientific Literature | ||
19. | ALA828111 | B | Concentration for 50% inhibition of human melanocortin-5 receptor expressed in CHO cells using [125I]NDP-alpha-MSH as radioligand | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
20. | ALA831727 | B | Selectivity of human melanocortin subtype-3 receptor over human melanocortin-4 receptor was determined | Homo sapiens | 10 | protein format | Scientific Literature |